PhD Scientific Days 2017

Oral Presentations: Clinical Sciences

Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort

L. Gonczi1, Z. Kurti1, K.B. Gecse1, Z. Vegh1, M. Rutka2, K. Farkas2, P.A. Golovics1, B.D. Lovasz1, J. Banai3, L. Bene4, B. Gasztonyi5, T. Kristof6, L. Lakatos7, P. Miheller8, F. Nagy2, K. Palatka9, M.Papp9, A. Patai10, A. Salamon11, T.Szamosi3, Z. Szepes2, G.T. Toth12, A. Vincze13, T. Molnar2, P.L.Lakatos1
1 Semmelweis University, First Department of Medicine, Budapest, Hungary,
2 University of Szeged, First Department of Internal Medicine, Szeged, Hungary,
3 Military Hospital – StateHealth Centre, Gastroenterology, Budapest, Hungary,
4 Peterfy Hospital, 1st Department of Medicine, Budapest, Hungary,
5 Zala County Hospital, 2nd Department of Medicine,Zalaegerszeg, Hungary,
6 B-A-Z County and University Teaching Hospital, 2nd Department ofMedicine, Miskolc, Hungary,
7 Csolnoky Ferenc Regional Hospital, Department of Internal Medicine, Veszprem, Hungary,
8 Semmelweis University, Second Departement of Internal Medicine, Budapest, Hungary,
9 University of Debrecen, Department of Gastroenterology, Debrecen, Hungary,
10 Markusovszky Hospital, Department of Medicine and Gastroenterology, Szombathely, Hungary,
11 Tolna County Teaching Hospital, Department of Gastroenterology,Szekszard, Hungary,
12 Janos Hospital, Department of Gastroenterology, Budapest, Hungary,
13 University of Pécs, 1st Department of Medicine, Pecs, Hungary